Clinical studies recruiting near Okayama

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Phase 3 · Okayama Saiseikai General Hospital · National Cancer Center Hospital East · NCT04288999 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · National Hospital Organization Okayama Medical Center · Pfizer · NCT05020236 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Okayama University Hospital · Daiichi Sankyo · NCT07022483 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Okayama University Hospital ( Site 1912) · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Okayama University Hospital ( Site 3425) · Merck Sharp & Dohme LLC · NCT06393374 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · National Hospital Organization Okayama Medical Center · Pfizer · NCT06758401 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · National Hospital Organization Okayama Medical Center · Pfizer · NCT07073820 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Okayama University Hospital · Hoffmann-La Roche · NCT06793215 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Okayama Rosai Hospital · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Okayama University Hospital · Eli Lilly and Company · NCT07415044 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Okayama University Hospital ( Site 2101) · Merck Sharp & Dohme LLC · NCT07216703 Endometrial Cancer Lymphadenectomy Trial
NA · Okayama University Hospital · Philipps University Marburg · NCT03438474 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Okayama City General Medical Center Okayama City Hospital · Pfizer · NCT05895786 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · Okayama University Hospital · Longboard Pharmaceuticals · NCT06660394 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · National Hospital Organization Okayama Medical Center · Pfizer · NCT07144280 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Okayama University Hospital ( Site 3807) · Merck Sharp & Dohme LLC · NCT06077760 A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2 · National Hospital Organization Okayama Medical Center · Janssen Research & Development, LLC · NCT04634552 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NA · Okayama Medical Center · AgNovos Healthcare, LLC · NCT04796350 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Okayama University Hospital · Boehringer Ingelheim · NCT06531824 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Okayama University Hospital · Amgen · NCT07005128 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Kawasaki Medical School Hospital · Boehringer Ingelheim · NCT07220083 Software as a Medical Device for the Treatment of Patients With PTSD
Phase 2/Phase 3 · Okayama Psychiatric Medical Center · Otsuka Medical Devices Co., Ltd. Japan · NCT06589505 A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Ad
Phase 2 · Okayama University Hospital /ID# 276299 · AbbVie · NCT07196644 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Okayama University Hospital ( Site 1164) · Merck Sharp & Dohme LLC · NCT06623422 A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · Okayama University Hospital · Taiho Oncology, Inc. · NCT05967689 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · AbbVie · NCT04928846 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785

Look up another city

Look up another condition